Related Experiment Video
Updated: May 31, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Raltegravir in pregnancy: a case series presentation
1Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg, Austria.
International Journal of STD & AIDS
|June 18, 2011
Summary
Antiretroviral therapy prevents HIV mother-to-child transmission. This case series examines raltegravir use in pregnant women, offering insights into its role in preventing transmission.
Area of Science:
- Virology
- Obstetrics
- Pharmacology
Background:
- Antiretroviral therapy (ART) is crucial for preventing mother-to-child transmission (MTCT) of Human Immunodeficiency Virus (HIV).
- Optimizing ART regimens during pregnancy is essential for maternal health and infant safety.
- Understanding the safety and efficacy of specific antiretroviral drugs in pregnancy is an ongoing area of research.
Observation:
- This study presents a case series of five pregnant women on antiretroviral therapy.
- These women included raltegravir in their ART regimen during pregnancy.
- The focus was on the use of raltegravir within a broader ART strategy.
Findings:
- Raltegravir was utilized as part of combination antiretroviral therapy in pregnant women.
- The case series provides preliminary data on the use of this specific integrase inhibitor during gestation.
- Further research is needed to fully characterize the outcomes associated with raltegravir use in pregnancy.
Implications:
- Findings contribute to the limited data on integrase inhibitors, such as raltegravir, in pregnant populations.
- This information can inform clinical decisions regarding ART choices for HIV-positive pregnant women.
- Further investigation into raltegravir's role in preventing HIV MTCT is warranted.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...